Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era

被引：1
作者：
Van Cutsem, Eric [1 ]
Tejpar, Sabine [1 ]
机构：
[1] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Leuven, Belgium
来源：
TARGETED ONCOLOGY | 2008年 / 3卷 / 04期
关键词：
Predictive markers; Colorectal cancer; EGFR; Targeted therapy;
D O I：
10.1007/s11523-008-0097-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：223 / 225
页数：3
相关论文
共 23 条
[11]   Design, synthesis, and antimalarial evaluation of thiazole-derived amino acids [J].
Karade, Hitendra N. ;
Acharya, B. N. ;
Sathe, Manisha ;
Kaushik, M. P. .
MEDICINAL CHEMISTRY RESEARCH, 2008, 17 (01) :19-29
[12]   Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab [J].
Khambata-Ford, Shirin ;
Garrett, Christopher R. ;
Meropol, Neal J. ;
Basik, Mark ;
Harbison, Christopher T. ;
Wu, Shujian ;
Wong, Tai W. ;
Huang, Xin ;
Takimoto, Chris H. ;
Godwin, Andrew K. ;
Tan, Benjamin R. ;
Krishnamurthi, Smitha S. ;
Burris, Howard A., III ;
Poplin, Elizabeth A. ;
Hidalgo, Manuel ;
Baselga, Jose ;
Clark, Edwin A. ;
Mauro, David J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3230-3237
[13]   KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer [J].
Lièvre, A ;
Bachet, JB ;
Le Corre, D ;
Boige, V ;
Landi, B ;
Emile, JF ;
Côté, JF ;
Tomasic, G ;
Penna, C ;
Ducreux, M ;
Rougier, P ;
Penault-Llorca, F ;
Laurent-Puig, P .
CANCER RESEARCH, 2006, 66 (08) :3992-3995
[14]   KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab [J].
Lievre, Astrid ;
Bachet, Jean-Baptiste ;
Boige, Valerie ;
Cayre, Anne ;
Le Corre, Delphine ;
Buc, Emmanuel ;
Ychou, Marc ;
Bouche, Olivier ;
Landi, Bruno ;
Louvet, Christophe ;
Andre, Thierry ;
Bibeau, Frederic ;
Diebold, Marie-Daniele ;
Rougier, Philippe ;
Ducreux, Michel ;
Tomasic, Gorana ;
Emile, Jean-Francois ;
Penault-Llorca, Frederique ;
Laurent-Puig, Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :374-379
[15]  
LOUPAKIS F, 2008, ASCO ANN M 2008
[16]   Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study [J].
Moroni, M ;
Veronese, S ;
Benvenuti, S ;
Marrapese, G ;
Sartore-Bianchi, A ;
Di Nicolantonio, F ;
Gambacorta, M ;
Siena, S ;
Bardelli, A .
LANCET ONCOLOGY, 2005, 6 (05) :279-286
[17]  
Nowacki M, 2007, ASCO ANN M 2007
[18]   Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab:: A fluorescent in situ hybridization study [J].
Personeni, Nicola ;
Fieuws, Steffen ;
Piessevaux, Hubert ;
De Hertogh, Gert ;
De Schutter, Jef ;
Biesmans, Bart ;
De Roock, Wendy ;
Capoen, An ;
Debiec-Rychter, Maria ;
Van Laethem, Jean-Luc ;
Peeters, Marc ;
Humblet, Yves ;
Van Cutsem, Eric ;
Tejpar, Sabine .
CLINICAL CANCER RESEARCH, 2008, 14 (18) :5869-5876
[19]   Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab [J].
Sartore-Bianchi, Andrea ;
Moroni, Mauro ;
Veronese, Silvio ;
Carnaghi, Carlo ;
Bajetta, Emilio ;
Luppi, Gabriele ;
Sobrero, Alberto ;
Barone, Carlo ;
Cascinu, Stefano ;
Colucci, Giuseppe ;
Cortesi, Enrico ;
Nichelatti, Michele ;
Gambacorta, Marcello ;
Siena, Salvatore .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3238-3245
[20]  
TEJPAR S, 2008, GI CANC S ORL 2008
123